Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Biomed Pharmacother ; 68(7): 881-5, 2014 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-25194446

RESUMO

Rheumatoid arthritis in HIV patients undergoing HAART is associated with increased risk of side effect. Elevation of uric acid (UA) is important in tissue damage, deposition of crystal in joints leads to the development of rheumatoid arthritis in the HAART complaint group. This study was carried out to investigate the relationship of uric acid, RA factor, ANA, ESR, cystatin C, urea and creatinine in the HAART complaint group. Moreover; the ratio of uric acid/cystatin C, uric acid/urea and uric acid/creatinine were also studied. To analyze the progression of HIV, the immunological parameters were correlated with uric acid. Our result showed a statistically high significant increase in uric acid, RA factor, ANA, ESR, cystatin C, urea and creatinine in the HAART complaint group when compared to HAART non-complaint group, early stage and control. The ratio of uric acid/cystatin C, uric acid/urea, uric acid/creatinine were significantly increased in the HAART complaint group. Statistically significant positive correlation was observed between uric acid and cystatin C, urea, creatinine, absolute CD4 and CD8 count. The increased level of uric acid, RA factor, ANA, ESR, cystatin C and increased ratio of uric acid/cystatin C in the HAART complaint group might conclude the mechanism underlying the increased risk for rheumatoid arthritis in the HAART complaint group which may relate to the combined effects of low-grade inflammation and renal dysfunction.


Assuntos
Terapia Antirretroviral de Alta Atividade/efeitos adversos , Infecções por HIV/tratamento farmacológico , Nefropatias/induzido quimicamente , Rim/efeitos dos fármacos , Osteonecrose/induzido quimicamente , Artrite Reumatoide/induzido quimicamente , Artrite Reumatoide/metabolismo , Creatinina/metabolismo , Cistatina C/metabolismo , Infecções por HIV/metabolismo , Humanos , Rim/metabolismo , Nefropatias/metabolismo , Osteonecrose/metabolismo , Fator Reumatoide/metabolismo , Ureia/metabolismo , Ácido Úrico
2.
Clin Chim Acta ; 412(11-12): 1151-4, 2011 May 12.
Artigo em Inglês | MEDLINE | ID: mdl-21300045

RESUMO

BACKGROUND: Acquired immune deficiency syndrome (AIDS) defines the end stage of Human immunodeficiency viral (HIV) infection before the introduction of highly active antiretroviral therapy (HAART). This study was carried out to assess the serum ß-2 microglobulin (B2M) as a marker for progression of HIV infected patients undergoing HAART. METHODS: Blood samples were collected from 50 subjects of HIV infected patients residing at semi urban area undergoing treatment at Chellam Hospital, Salem, India. Twenty five age-matched healthy subjects were taken as control group. Serum B2M level was measured by using enzyme immunoassay, absolute CD4 and CD8 counts were carried out by single platform (SP) technology using a flow cytometer. Viral RNA was measured by real time PCR. The serum LDH level and total WBC count were also measured. RESULTS: Our result showed a statistically high significant increase in B2M in HIV patients on HAART non complaint group whereas absolute CD4, CD8 count, CD4/CD8 ratio and WBC count were decreased significantly when compared to control and HAART complaint group. Statistically a significant negative correlation was observed between B2M and absolute CD4, CD8 count, CD4/CD8 ratio and WBC count. B2M showed a significantly positive correlation with viral RNA and LDH values. CONCLUSIONS: The increase of B2M and reduced absolute CD4, CD8 count, CD4/CD8 ratio and WBC count in HIV patients on HAART non complaint group may have a contributory role in the immune progression of HIV with interruption of HAART. B2M plays an important role in the diagnosis of HIV and might indicate HIV progression.


Assuntos
Infecções por HIV/tratamento farmacológico , Infecções por HIV/imunologia , Microglobulina beta-2/sangue , Terapia Antirretroviral de Alta Atividade , Biomarcadores/sangue , Relação CD4-CD8 , Antígenos CD8/metabolismo , Progressão da Doença , Infecções por HIV/sangue , Infecções por HIV/metabolismo , Humanos , L-Lactato Desidrogenase/metabolismo , Contagem de Leucócitos , RNA Viral/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA